share_log

Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital

Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital

警惕上海友善醫療器械(HKG:1501)及其資本回報
Simply Wall St ·  2022/06/10 20:06

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. However, after investigating Shanghai Kindly Medical Instruments (HKG:1501), we don't think it's current trends fit the mold of a multi-bagger.

你知道嗎,有一些財務指標可以提供潛在的多管齊下的線索?理想情況下,一家企業將呈現兩種趨勢;第一,增長返回關於已使用資本(ROCE),第二,增加金額已動用資本的比例。歸根結底,這表明它是一家正在以越來越高的回報率對利潤進行再投資的企業。不過,經過調查,上海和善醫療器械有限公司(HKG:1501),我們認為目前的趨勢不符合多袋子模式。

Understanding Return On Capital Employed (ROCE)

瞭解資本回報率(ROCE)

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Shanghai Kindly Medical Instruments, this is the formula:

如果你以前沒有使用過ROCE,它衡量的是一家公司從業務資本中獲得的“回報”(税前利潤)。要計算上海和善醫療器械的這一指標,公式如下:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

已動用資本回報率=息税前收益(EBIT)?(總資產-流動負債)

0.079 = CN¥116m ÷ (CN¥1.6b - CN¥153m) (Based on the trailing twelve months to December 2021).

0.079=CN元1.16億?(CN元16億-CN元1.53億)(根據截至2021年12月的往績12個月計算).

So, Shanghai Kindly Medical Instruments has an ROCE of 7.9%. In absolute terms, that's a low return and it also under-performs the Medical Equipment industry average of 10%.

所以,上海和善醫療器械的淨資產收益率為7.9%。按絕對值計算,這是一個較低的回報率,也低於醫療設備行業10%的平均水平。

View our latest analysis for Shanghai Kindly Medical Instruments

查看我們對上海和善醫療器械的最新分析

SEHK:1501 Return on Capital Employed June 10th 2022
聯交所:1501已動用資本回報率2022年6月10日

In the above chart we have measured Shanghai Kindly Medical Instruments' prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering Shanghai Kindly Medical Instruments here for free.

在上面的圖表中,我們衡量了上海仁慈醫療器械公司之前的淨資產收益率和之前的表現,但可以説,未來更重要。如果您願意,您可以在這裏查看上海和善醫療器械分析師的預測免費的。

What Can We Tell From Shanghai Kindly Medical Instruments' ROCE Trend?

從上海友善醫療器械的ROCE趨勢中我們可以看出什麼?

When we looked at the ROCE trend at Shanghai Kindly Medical Instruments, we didn't gain much confidence. To be more specific, ROCE has fallen from 21% over the last five years. However, given capital employed and revenue have both increased it appears that the business is currently pursuing growth, at the consequence of short term returns. If these investments prove successful, this can bode very well for long term stock performance.

當我們看着上海仁慈醫療器械公司的ROCE趨勢時,我們並沒有獲得太多信心。更具體地説,ROCE在過去五年中從21%下降。然而,鑑於已動用資本和收入都有所增加,該業務目前似乎正在追求增長,這是短期回報的結果。如果這些投資被證明是成功的,這可能是長期股票表現的好兆頭。

The Bottom Line

底線

While returns have fallen for Shanghai Kindly Medical Instruments in recent times, we're encouraged to see that sales are growing and that the business is reinvesting in its operations. And there could be an opportunity here if other metrics look good too, because the stock has declined 58% in the last year. So we think it'd be worthwhile to look further into this stock given the trends look encouraging.

雖然最近上海仁慈醫療器械的回報率有所下降,但我們看到銷售額在增長,而且該業務正在對其業務進行再投資,這讓我們感到鼓舞。如果其他指標也看起來不錯,這可能是一個機會,因為該股在過去一年裏下跌了58%。因此,我們認為,鑑於趨勢看起來令人鼓舞,進一步研究這隻股票是值得的。

One more thing: We've identified 2 warning signs with Shanghai Kindly Medical Instruments (at least 1 which is a bit concerning) , and understanding these would certainly be useful.

還有一件事:我們已經確定了2個警告標誌與上海和善醫療器械(至少1個有點令人擔憂)合作,瞭解這些肯定會有所幫助。

For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.

對於那些喜歡投資於穩固的公司,看看這個免費資產負債表穩健、股本回報率高的公司名單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論